Efficacy and tolerability of enteral formulations of ibuprofen in the treatment of patent ductus arteriosus in preterm infants.
Background: The persistence of a patent ductus arteriosus (PDA) in preterm infants complicates their clinical course and may contribute to increased morbidity. Intravenous preparations of ibuprofen constitute one of the standard therapies for closure of a PDA. However, the unavailability of intraven...
| Publicado en: | Clinical Therapeutics Vol. 32; no. 10; pp. 1740 - 1749 |
|---|---|
| Autores principales: | , |
| Formato: | research systematic review Journal Article |
| Publicado: |
Elsevier B.V.
Sep2010
|
| Acceso en línea: | Ver este registro en EBSCOhost |